Cargando…
2-(2-Benzofuranyl)-2-imidazoline treatment within 5 hours after cerebral ischemia/reperfusion protects the brain
We previously demonstrated that administering 2-(2-benzofuranyl)-2-imidazolin (2-BFI), an imidazoline I2 receptor agonist, immediately after ischemia onset can protect the brain from ischemic insult. However, immediate administration after stroke is difficult to realize in the clinic. Thus, the ther...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6199951/ https://www.ncbi.nlm.nih.gov/pubmed/30323139 http://dx.doi.org/10.4103/1673-5374.241461 |
_version_ | 1783365242998226944 |
---|---|
author | Zhang, Zheng Yang, Jin-Long Zhang, Lin-Lei Chen, Zhen-Zhen Chen, Jia-Ou Cao, Yun-Gang Qu, Man Lin, Xin-Da Ji, Xun-Ming Han, Zhao |
author_facet | Zhang, Zheng Yang, Jin-Long Zhang, Lin-Lei Chen, Zhen-Zhen Chen, Jia-Ou Cao, Yun-Gang Qu, Man Lin, Xin-Da Ji, Xun-Ming Han, Zhao |
author_sort | Zhang, Zheng |
collection | PubMed |
description | We previously demonstrated that administering 2-(2-benzofuranyl)-2-imidazolin (2-BFI), an imidazoline I2 receptor agonist, immediately after ischemia onset can protect the brain from ischemic insult. However, immediate administration after stroke is difficult to realize in the clinic. Thus, the therapeutic time window of 2-BFI should be determined. Sprague-Dawley rats provided by Wenzhou Medical University in China received right middle cerebral artery occlusion for 120 minutes, and were treated with 2-BFI (3 mg/kg) through the caudal vein at 0, 1, 3, 5, 7, and 9 hours after reperfusion. Neurological function was assessed using the Longa's method. Infarct volume was measured by 2,3,5-triphenyltetrazolium chloride assay. Morphological changes in the cortical penumbra were observed by hematoxylin-eosin staining under transmission electron microscopy. The apoptosis levels in the ipsilateral cortex were examined with terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling (TUNEL) assay. The protein expression of Bcl-2 and BAX was detected using immunohistochemistry. We found the following: Treatment with 2-BFI within 5 hours after reperfusion obviously improved neurological function. Administering 2-BFI within 9 hours after ischemia/reperfusion decreased infarct volume and alleviated apoptosis. 2-BFI administration at different time points after reperfusion alleviated the pathological damage of the ischemic penumbra and reduced the number of apoptotic neurons, but the protective effect was more obvious when administered within 5 hours. Administration of 2-BFI within 5 hours after reperfusion remarkably increased Bcl-2 expression and decreased BAX expression. To conclude, 2-BFI shows potent neuroprotective effects when administered within 5 hours after reperfusion, seemingly by up-regulating Bcl-2 and down-regulating BAX expression. The time window provided clinical potential for ischemic stroke by 2-BFI. |
format | Online Article Text |
id | pubmed-6199951 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-61999512018-12-01 2-(2-Benzofuranyl)-2-imidazoline treatment within 5 hours after cerebral ischemia/reperfusion protects the brain Zhang, Zheng Yang, Jin-Long Zhang, Lin-Lei Chen, Zhen-Zhen Chen, Jia-Ou Cao, Yun-Gang Qu, Man Lin, Xin-Da Ji, Xun-Ming Han, Zhao Neural Regen Res Research Article We previously demonstrated that administering 2-(2-benzofuranyl)-2-imidazolin (2-BFI), an imidazoline I2 receptor agonist, immediately after ischemia onset can protect the brain from ischemic insult. However, immediate administration after stroke is difficult to realize in the clinic. Thus, the therapeutic time window of 2-BFI should be determined. Sprague-Dawley rats provided by Wenzhou Medical University in China received right middle cerebral artery occlusion for 120 minutes, and were treated with 2-BFI (3 mg/kg) through the caudal vein at 0, 1, 3, 5, 7, and 9 hours after reperfusion. Neurological function was assessed using the Longa's method. Infarct volume was measured by 2,3,5-triphenyltetrazolium chloride assay. Morphological changes in the cortical penumbra were observed by hematoxylin-eosin staining under transmission electron microscopy. The apoptosis levels in the ipsilateral cortex were examined with terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling (TUNEL) assay. The protein expression of Bcl-2 and BAX was detected using immunohistochemistry. We found the following: Treatment with 2-BFI within 5 hours after reperfusion obviously improved neurological function. Administering 2-BFI within 9 hours after ischemia/reperfusion decreased infarct volume and alleviated apoptosis. 2-BFI administration at different time points after reperfusion alleviated the pathological damage of the ischemic penumbra and reduced the number of apoptotic neurons, but the protective effect was more obvious when administered within 5 hours. Administration of 2-BFI within 5 hours after reperfusion remarkably increased Bcl-2 expression and decreased BAX expression. To conclude, 2-BFI shows potent neuroprotective effects when administered within 5 hours after reperfusion, seemingly by up-regulating Bcl-2 and down-regulating BAX expression. The time window provided clinical potential for ischemic stroke by 2-BFI. Medknow Publications & Media Pvt Ltd 2018-12 /pmc/articles/PMC6199951/ /pubmed/30323139 http://dx.doi.org/10.4103/1673-5374.241461 Text en Copyright: © Neural Regeneration Research http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Research Article Zhang, Zheng Yang, Jin-Long Zhang, Lin-Lei Chen, Zhen-Zhen Chen, Jia-Ou Cao, Yun-Gang Qu, Man Lin, Xin-Da Ji, Xun-Ming Han, Zhao 2-(2-Benzofuranyl)-2-imidazoline treatment within 5 hours after cerebral ischemia/reperfusion protects the brain |
title | 2-(2-Benzofuranyl)-2-imidazoline treatment within 5 hours after cerebral ischemia/reperfusion protects the brain |
title_full | 2-(2-Benzofuranyl)-2-imidazoline treatment within 5 hours after cerebral ischemia/reperfusion protects the brain |
title_fullStr | 2-(2-Benzofuranyl)-2-imidazoline treatment within 5 hours after cerebral ischemia/reperfusion protects the brain |
title_full_unstemmed | 2-(2-Benzofuranyl)-2-imidazoline treatment within 5 hours after cerebral ischemia/reperfusion protects the brain |
title_short | 2-(2-Benzofuranyl)-2-imidazoline treatment within 5 hours after cerebral ischemia/reperfusion protects the brain |
title_sort | 2-(2-benzofuranyl)-2-imidazoline treatment within 5 hours after cerebral ischemia/reperfusion protects the brain |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6199951/ https://www.ncbi.nlm.nih.gov/pubmed/30323139 http://dx.doi.org/10.4103/1673-5374.241461 |
work_keys_str_mv | AT zhangzheng 22benzofuranyl2imidazolinetreatmentwithin5hoursaftercerebralischemiareperfusionprotectsthebrain AT yangjinlong 22benzofuranyl2imidazolinetreatmentwithin5hoursaftercerebralischemiareperfusionprotectsthebrain AT zhanglinlei 22benzofuranyl2imidazolinetreatmentwithin5hoursaftercerebralischemiareperfusionprotectsthebrain AT chenzhenzhen 22benzofuranyl2imidazolinetreatmentwithin5hoursaftercerebralischemiareperfusionprotectsthebrain AT chenjiaou 22benzofuranyl2imidazolinetreatmentwithin5hoursaftercerebralischemiareperfusionprotectsthebrain AT caoyungang 22benzofuranyl2imidazolinetreatmentwithin5hoursaftercerebralischemiareperfusionprotectsthebrain AT quman 22benzofuranyl2imidazolinetreatmentwithin5hoursaftercerebralischemiareperfusionprotectsthebrain AT linxinda 22benzofuranyl2imidazolinetreatmentwithin5hoursaftercerebralischemiareperfusionprotectsthebrain AT jixunming 22benzofuranyl2imidazolinetreatmentwithin5hoursaftercerebralischemiareperfusionprotectsthebrain AT hanzhao 22benzofuranyl2imidazolinetreatmentwithin5hoursaftercerebralischemiareperfusionprotectsthebrain |